Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q8WXF7 (ATLA1_HUMAN)

Last modified November 24, 2009. Version 72. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Atlastin-1
    EC=3.6.5.-
Alternative name(s):
    Spastic paraplegia 3A
    Guanine nucleotide-binding protein 3
    GTP-binding protein 3
      Short name=GBP-3
      Short name=hGBP3
    Brain-specific GTP-binding protein
Gene names
Name: ATL1
Synonyms: GBP3, SPG3A
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length558 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

GTPase tethering membranes through formation of trans-homooligomer and mediating homotypic fusion of endoplasmic reticulum membranes. Functions in endoplasmic reticulum tubular network biogenesis. May also regulate Golgi biogenesis. May regulate axonal development. Ref.8 Ref.11 Ref.12 Ref.14

Subunit structure

Homooligomer. Interacts (via N-terminal region) with MAP4K4 (via CNH regulatory domain). Interacts with REEP5, RTN3 and RTN4 (via the transmembrane region). Interacts with SPAST; interaction is direct. May interact with TMED2. Ref.8 Ref.11 Ref.14 Ref.2 Ref.9 Ref.10

Subcellular location

Endoplasmic reticulum membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein. Cell projectionaxon By similarity.

Tissue specificity

Expressed predominantly in the adult and fetal central nervous system. Measurable expression in all tissues examined, although expression in adult brain is at least 50-fold higher than in other tissues. Detected predominantly in pyramidal neurons in the cerebral cortex and the hippocampus of the brain. Expressed in upper and lower motor neurons (at protein level). Ref.8 Ref.11 Ref.12

Involvement in disease

Defects in ATL1 are the cause of spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600]; also known as Strumpell-Lorrain syndrome. Spastic paraplegia is a degenerative spinal cord disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Ref.1 Ref.15 Ref.16

Sequence similarities

Belongs to the GBP family. Atlastin subfamily.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

Reep5Q608701EBI-2410266,EBI-2410304From a different organism.
Rtn3Q9ES97-31EBI-2410266,EBI-1487798From a different organism.
RTN4Q9NQC3-11EBI-2410266,EBI-715972
Rtn4Q9JK11-31EBI-2410266,EBI-920002From a different organism.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 558558Atlastin-1
PRO_0000190971

Regions

Topological domain1 – 449449Cytoplasmic Ref.8
Transmembrane450 – 47021 Potential
Topological domain4711Lumenal Potential
Transmembrane472 – 49221 Potential
Topological domain493 – 55866Cytoplasmic Ref.8
Nucleotide binding74 – 818GTP Potential
Nucleotide binding146 – 1505GTP Potential
Region448 – 558111Sufficient for membrane association
Coiled coil412 – 43928 Potential

Amino acid modifications

Modified residue101Phosphoserine By similarity
Modified residue181Phosphothreonine By similarity
Modified residue221Phosphoserine Ref.13
Modified residue231Phosphoserine Ref.13

Natural variations

Natural variant431D → E: dbSNP rs17850684. Ref.6
VAR_058963
Natural variant1611A → P in SPG3; affects endoplasmic reticulum and Golgi morphology. Ref.11 Ref.16
VAR_019446
Natural variant1931F → C: dbSNP rs17850683. Ref.6
VAR_058964
Natural variant2171R → Q in SPG3; alters endoplasmic reticulum morphology. Ref.12 Ref.15
VAR_017146
Natural variant2391R → C in SPG3; affects endoplasmic reticulum and Golgi morphology. Ref.11 Ref.1
VAR_017147
Natural variant2471H → P in SPG3. Ref.16
VAR_019447
Natural variant2581H → R in SPG3. Ref.1
VAR_017148
Natural variant2591S → Y in SPG3. Ref.1
VAR_017149

Experimental info

Mutagenesis801K → A: Alters endoplasmic reticulum morphogenesis. Ref.12
Mutagenesis1511F → S: Affects endoplasmic reticulum and Golgi morphology. Ref.11
Mutagenesis1621T → P: Affects endoplasmic reticulum and Golgi morphology. Ref.11
Mutagenesis3981S → Y: Affects endoplasmic reticulum and Golgi morphology. Ref.11
Mutagenesis4951R → W: Affects endoplasmic reticulum and Golgi morphology. Ref.11

Sequences

Sequence LengthMass (Da)Tools
Q8WXF7-1 [UniParc].

Last modified March 1, 2002. Version 1.
Checksum: 68A33C39DD43504C

FASTA55863,544
        10         20         30         40         50         60 
MAKNRRDRNS WGGFSEKTYE WSSEEEEPVK KAGPVQVLIV KDDHSFELDE TALNRILLSE 

        70         80         90        100        110        120 
AVRDKEVVAV SVAGAFRKGK SFLMDFMLRY MYNQESVDWV GDYNEPLTGF SWRGGSERET 

       130        140        150        160        170        180 
TGIQIWSEIF LINKPDGKKV AVLLMDTQGT FDSQSTLRDS ATVFALSTMI SSIQVYNLSQ 

       190        200        210        220        230        240 
NVQEDDLQHL QLFTEYGRLA MEETFLKPFQ SLIFLVRDWS FPYEFSYGAD GGAKFLEKRL 

       250        260        270        280        290        300 
KVSGNQHEEL QNVRKHIHSC FTNISCFLLP HPGLKVATNP NFDGKLKEID DEFIKNLKIL 

       310        320        330        340        350        360 
IPWLLSPESL DIKEINGNKI TCRGLVEYFK AYIKIYQGEE LPHPKSMLQA TAEANNLAAV 

       370        380        390        400        410        420 
ATAKDTYNKK MEEICGGDKP FLAPNDLQTK HLQLKEESVK LFRGVKKMGG EEFSRRYLQQ 

       430        440        450        460        470        480 
LESEIDELYI QYIKHNDSKN IFHAARTPAT LFVVIFITYV IAGVTGFIGL DIIASLCNMI 

       490        500        510        520        530        540 
MGLTLITLCT WAYIRYSGEY RELGAVIDQV AAALWDQGST NEALYKLYSA AATHRHLYHQ 

       550 
AFPTPKSEST EQSEKKKM 

« Hide

References

« Hide 'large scale' references
[1]"Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia."
Zhao X., Alvarado D., Rainier S., Lemons R., Hedera P., Weber C.H., Tukel T., Apak M., Heiman-Patterson T., Ming L., Bui M., Fink J.K.
Nat. Genet. 29:326-331(2001) [PubMed: 11685207] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SPG3 CYS-239; ARG-258 AND TYR-259.
[2]"A novel GTP-binding protein hGBP3 interacts with NIK/HGK."
Luan Z., Zhang Y., Liu A., Man Y., Cheng L., Hu G.
FEBS Lett. 530:233-238(2002) [PubMed: 12387898] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH MAP4K4.
[3]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Thalamus.
[4]"The DNA sequence and analysis of human chromosome 14."
Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., Du H. expand/collapse author list , Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M., Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V., Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F., Waterston R., Hood L., Weissenbach J.
Nature 421:601-607(2003) [PubMed: 12508121] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS GLU-43 AND CYS-193.
Tissue: Eye.
[7]Mei G., Yu W., Gibbs R.A.
Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 80-558.
Tissue: Brain.
[8]"Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin."
Zhu P.-P., Patterson A., Lavoie B., Stadler J., Shoeb M., Patel R., Blackstone C.
J. Biol. Chem. 278:49063-49071(2003) [PubMed: 14506257] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, REGION, TOPOLOGY, SUBUNIT.
[9]"Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners."
Sanderson C.M., Connell J.W., Edwards T.L., Bright N.A., Duley S., Thompson A., Luzio J.P., Reid E.
Hum. Mol. Genet. 15:307-318(2006) [PubMed: 16339213] [Abstract]
Cited for: INTERACTION WITH SPAST, SUBCELLULAR LOCATION.
[10]"Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance."
Evans K.J., Keller C., Pavur K., Glasgow K., Conn B., Lauring B.P.
Proc. Natl. Acad. Sci. U.S.A. 103:10666-10671(2006) [PubMed: 16815977] [Abstract]
Cited for: INTERACTION WITH SPAST.
[11]"Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis."
Namekawa M., Muriel M.-P., Janer A., Latouche M., Dauphin A., Debeir T., Martin E., Duyckaerts C., Prigent A., Depienne C., Sittler A., Brice A., Ruberg M.
Mol. Cell. Neurosci. 35:1-13(2007) [PubMed: 17321752] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANTS SPAG3 PRO-161 AND CYS-239, MUTAGENESIS OF PHE-151; THR-162; SER-398 AND ARG-495, INTERACTION WITH TMED2, TISSUE SPECIFICITY.
[12]"Atlastin GTPases are required for Golgi apparatus and ER morphogenesis."
Rismanchi N., Soderblom C., Stadler J., Zhu P.-P., Blackstone C.
Hum. Mol. Genet. 17:1591-1604(2008) [PubMed: 18270207] [Abstract]
Cited for: FUNCTION, CHARACTERIZATION OF VARIANT SPAG3 GLN-217, MUTAGENESIS OF LYS-80, TISSUE SPECIFICITY.
[13]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-23, MASS SPECTROMETRY.
Tissue: Platelet.
[14]"A class of dynamin-like GTPases involved in the generation of the tubular ER network."
Hu J., Shibata Y., Zhu P.-P., Voss C., Rismanchi N., Prinz W.A., Rapoport T.A., Blackstone C.
Cell 138:549-561(2009) [PubMed: 19665976] [Abstract]
Cited for: FUNCTION, INTERACTION WITH REEP5; RTN3 AND RTN4, SUBCELLULAR LOCATION.
[15]"Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia."
Muglia M., Magariello A., Nicoletti G., Patitucci A., Gabriele A.L., Conforti F.L., Mazzei R., Caracciolo M., Ardito B., Lastilla M., Tedeschi G., Quattrone A.
Ann. Neurol. 51:794-795(2002) [PubMed: 12112092] [Abstract]
Cited for: VARIANT SPG3 GLN-217.
[16]"Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus."
Sauter S.M., Engel W., Neumann L.M., Kunze J., Neesen J.
Hum. Mutat. 23:98-98(2004) [PubMed: 14695538] [Abstract]
Cited for: VARIANTS SPG3 PRO-161 AND PRO-247.
+Additional computationally mapped references.

Web resources

Cross-references

Sequence databases

AY032844 mRNA. Translation: AAK51160.1. Different initiation.
AF444143 mRNA. Translation: AAL37898.1.
AK290185 mRNA. Translation: BAF82874.1.
AL118556 Genomic DNA. No translation available.
AL606834 Genomic DNA. No translation available.
CH471078 Genomic DNA. Translation: EAW65706.1.
BC010708 mRNA. Translation: AAH10708.2.
AF131801 mRNA. Translation: AAD20047.1. Different initiation.
IPIIPI00103530.
RefSeqNP_001121185.1.
NP_056999.2.
NP_853629.2.
UniGeneHs.584905

3D structure databases

ModBaseSearch...

Protein-protein interaction databases

IntActQ8WXF7. 4 interactions.
STRINGQ8WXF7.

PTM databases

PhosphoSiteQ8WXF7.

Proteomic databases

PRIDEQ8WXF7.

Genome annotation databases

EnsemblENST00000358385; ENSP00000351155; ENSG00000198513; Homo sapiens. [Genome view]
GeneID51062.
UCSCuc001wyf.2. human.

Organism-specific databases

CTD51062.
GeneCardsGC14P050097.
H-InvDBHIX0011643.
HGNCHGNC:11231. ATL1.
MIM182600. phenotype.
606439. gene.
Orphanet100984. Autosomal dominant spastic paraplegia, type 3.
PharmGKBPA36061.
GenAtlasSearch...

Phylogenomic databases

HOVERGENQ8WXF7.
OMAATHRHLY

Gene expression databases

ArrayExpressQ8WXF7.
BgeeQ8WXF7.
CleanExHS_ATL1.
GenevestigatorQ8WXF7.
GermOnlineENSG00000198513. Homo sapiens.

Family and domain databases

InterProIPR015900. Guanylate-bd-like_C.
IPR015894. Guanylate-bd_N.
[Graphical view]
PfamPF02263. GBP. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio53649.
SOURCESearch...

Entry information

Entry nameATLA1_HUMAN
AccessionPrimary (citable) accession number: Q8WXF7
Secondary accession number(s): A8K2C0, O95890, Q96FK0
Entry history
Integrated into UniProtKB/Swiss-Prot: October 24, 2003
Last sequence update: March 1, 2002
Last modified: November 24, 2009
This is version 72 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 14

Human chromosome 14: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents